Vascular Closure Device Market Growth, Size, Share, Trends, Key Players Analysis, and Forecast till 2031

Vascular Closure Device Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Active Approximators, Passive Approximators, and External Hemostatic Devices), Access (Femoral Access and Radial Access), Procedure (Interventional Cardiology, Interventional Radiology, and Endovascular Surgery), and End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography

  • Report Code : TIPHE100001123
  • Category : Medical Device
  • No. of Pages : 150
Buy Now

The vascular closure device market size is projected to reach US$ 3.03 billion by 2031 from US$ 1.73 billion in 2023. The market is expected to register a CAGR of 7.1% in 2023–2031. The global market's growth is primarily attributed to the higher prevalence of cardiovascular diseases and burgeoning demand for minimally invasive devices. However, the risk of infection related to vascular closure devices may hinders the market growth.

Vascular Closure Device Market Analysis

Vascular closure devices (VCDs) are medical devices that are utilized following endovascular surgery or other cardiovascular procedures that need a catheterization to achieve hemostasis of the small hole in the artery. Catheterization is necessary for a variety of cardiovascular operations, including interventional procedures like coronary thrombectomy, angioplasty, and stent insertion that aid in the diagnosis of damaged blood arteries. The one of the leading causes of death worldwide is cardiovascular illnesses, which include acute myocardial infarction, angina pectoris, and atherosclerosis. Therefore, the market expansion for vascular closure devices is driven by the higher demand for minimally invasive devices.

Vascular Closure Device Market Overview

Cardiovascular diseases such as atherosclerosis, angina pectoris, and acute myocardial infarction are the major causes of mortality in the world. As per data provided by the World Health Organization (WHO), cardiovascular diseases cause nearly 17.9 million deaths every year, which makes it a leading cause of mortality among all noncommunicable diseases, followed by cancer, chronic respiratory diseases, and diabetes (including deaths associated with renal disorders). According to the World Heart Federation, high cholesterol causes 4.4 million deaths yearly, and ∼24% of cardiovascular-related deaths are associated with high low-density lipoprotein (LDL) levels. According to a study published in January 2023 by NCBI, in the US, the number of people aged 50 years and older is likely to reach 221.13 million by 2050 from 137.25 million in 2020. Among people from this age group, the number of people suffering from at least one chronic disease is projected to rise by 99.5%, reaching 142.66 million by 2050 from 71.52 million in 2020. Moreover, ~14 million people aged 50 and above are likely to have comorbidities in 2050.

Vascular closure devices (VCDs) offer a new way to enhance patients’ comfort and ambulation after invasive cardiovascular treatments via femoral arterial access. Vascular closure devices are used in different therapeutic approaches to provide easy, quick, and reliable hemostasis. In the US, femoral arterial access is the most often used vascular access technique for percutaneous coronary intervention (PCI) and coronary angiography. Nevertheless, there has been an increase in traction toward cardiac catheterization and percutaneous coronary intervention (PCI) via radial access in recent years. Several femoral artery closure devices have been developed to shorten vascular closure times, with variable rates of vascular complications observed in clinical trials. Vascular closure devices (VCDs) have emerged as an effective alternative to traditional mechanical compression procedures performed after cardiac catheterization. VCDs reduce the time of hospital stays, speed up patient mobilization, and shorten the time needed to achieve hemostasis. Thus, the vascular closure device market is growing notably with the increasing prevalence of cardiovascular diseases.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Vascular Closure Device Market: Strategic Insights

Vascular Closure Device Market

  • CAGR (2023 - 2031)
  • Market Size 2023
    US$ 1.73 Billion
  • Market Size 2031
    US$ 3.03 Billion

Market Dynamics

  • Increasing procedure volume of cardiovascular surgeries is driving the Market Growth
  • Higher Demand for advanced Minimally Invasive Devices Favouring the Market Growth
  • Growth Stategies Adopted by Major Players to provide Lucrative Opportunities

Key Players

  • Cordis Corp.
  • Transluminal Technologies LLC
  • Vasorum Ltd
  • Haemonetics Corp.
  • Abbott Laboratories
  • Becton Dickinson and Co
  • Cardinal Health Inc
  • Medtronic Plc

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Product Type
  • Active Approximators
  • Passive Approximators
  • External Hemostatic Devices
  • Femoral Access and Radial Access
  • Interventional Cardiology
  • Interventional Radiology
  • Endovascular Surgery
End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Vascular Closure Device Market Drivers and Opportunities

Higher Demand for Minimally Invasive Devices Favors Market

Improvements in medical science and technologies have given way to minimally invasive devices, which can aid in the replacement of traditional painful surgical methods by minimally invasive or non-invasive methods. Minimally invasive techniques have gained popularity in surgical fields such as cardiac surgery. Many of these procedures are performed using femoral cannulation for extracorporeal circulation. Vascular closure devices have gained popularity as they reduce invasiveness and supersede surgical cut-downs to cannulate the femoral artery. Vascular closure devices are mainly used in transcatheter and endovascular interventions to enable wound healing and reduce procedure time.

Angiography is one of the common procedures performed in a wide variety of specialties, including vascular surgery, interventional radiology, and diagnostic and interventional cardiology. Vascular closure devices are useful in the settings of a large body habitus, as well as anticoagulation and antiplatelet therapies. They are also used in cases where extended bed rest may not be desirable (such as a patient with extensive pressure ulcers). A vascular closure device with resorbable collagen material, which eliminates the use of suture materials, has been introduced for transfemoral transcatheter aortic valve implantation (TAVI). For instance, the MANTA device by Teleflex Medical Inc. is adequate for the closure of arterial access sites of up to 25 Fr. Safety and efficacy of the system were demonstrated in a real-world TAVI patient cohort. Thus, the increasing demand for minimally invasive devices drives the vascular closure devices market growth

Untapped Potential of Emerging Economies – An Opportunity in Vascular Closure Device Market

Vascular closure devices market players should anticipate significant growth opportunities in emerging nations like India, China, Argentina, Brazil, UAE, and South Africa because of factors like growing disposable incomes, an aging patient population, increased R&D, improved healthcare infrastructure, rising awareness of CVD, and relatively lax guidelines in comparison to developed nations. Russia, Brazil, China, India, and South Africa together accounted for one-third of all global health spending as of 2022, according to the World Economic Forum. The World Bank reports that from 2018 to 2019, health spending grew by 3.01% in India and 5.35% in China. Also, there has been an upsurge in heart failure cases over the past decade in emerging markets, which has resulted in a large number of cardiovascular disease-related deaths. As per the India Brand Equity Foundation, hospitals contribute to ~70% of the revenue of the healthcare sector in India. In China, the number of private hospitals reached up to 36,000 in 2022. Moreover, the private hospitals account for ~57% of total number of hospitals in the country. The number of surgical centers and hospitals in developing markets is estimated to grow due to rising healthcare spending and a surge in the target patient population. Thus, the development of healthcare facilities in developing economies, along with a surge in the number of hospitals, would propel the awareness and adoption of vascular closure devices in emerging economies. Further, vast competition in developed or matured markets encourages vascular closure device manufacturers to focus on developing markets, which is likely to offer growth opportunities for vascular closure device providers to attain a significant position in the market.

Vascular Closure Device Market Report Segmentation Analysis

Key segments that contributed to the derivation of the vascular closure device market analysis are product type, access, procedure, and end users.

  • Based on product type, the vascular closure device market is divided into active approximators, passive approximators, and external hemostatics. The passive approximators device segment held a higher market share in 2023.
  • Based on access, the market is segmented into Femoral Access and Radial Access.
  • In terms of procedure, the market is segmented into interventional cardiology, interventional radiology, and endovascular surgical.
  • In terms of end users, the market is segmented into Hospitals, ABSc, and Others.

Vascular Closure Device Market Share Analysis by Geography

The geographic scope of the vascular closure device market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America.

In North America, the vascular closure device market is currently experiencing exponential growth during the forecast years. The North America vascular closure devices market is segmented into the US, Canada, and Mexico; the US held the largest share of the market in 2023. The US is a hub for medical innovations and technological advancements in healthcare. Continuous advancements in technologies associated with minimally invasive procedures, improvements in closure device technologies, and the introduction of novel closure devices contribute to the growth of the vascular closure devices market in the US. For instance, in March 2023, Haemonetics Corporation (US) invested ~US$ 31.72 million (EUR 30 million) in Vivasure Medical Limited. In March 2023, Vivasure Medical announced FDA IDE approval to Initiate a US Pivotal Study evaluating the safety and effectiveness of the Vivasure PerQseal Closure Device System. In 2021, VASCADE MVP was the first and only FDA-approved vascular closure device indicated for use following atrial fibrillation (AF) ablation to allow same-day discharge.

Vascular Closure Device Market Report Scope

Report Attribute Details
Market size in 2023 US$ 1.73 Billion
Market Size by 2031 US$ 3.03 Billion
Global CAGR (2023 - 2031) 7.1%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Product Type
  • Active Approximators
  • Passive Approximators
  • External Hemostatic Devices
By Access
  • Femoral Access and Radial Access
By Procedure
  • Interventional Cardiology
  • Interventional Radiology
  • Endovascular Surgery
By End User
  • Hospitals
  • Ambulatory Surgical Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Cordis Corp.
  • Transluminal Technologies LLC
  • Vasorum Ltd
  • Haemonetics Corp.
  • Abbott Laboratories
  • Becton Dickinson and Co
  • Cardinal Health Inc
  • Medtronic Plc
    • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

    Vascular Closure Device Market News and Recent Developments

    The vascular closure device market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for innovations, business expansion, and strategies:

    • In May 2022, Teleflex Inc., a global provider of medical technologies, announced that it received Health Canada approval for the MANTA Vascular Closure Device – the first commercially available biomechanical vascular closure device designed specifically for large bore femoral arterial access site closure. This approval marks an important milestone in the regulatory plan to expand the availability of the MANTA Device globally and provide Canadian clinicians access to another uniquely designed device from Teleflex. (Source: Teleflex Inc. company website)

    Vascular Closure Device Market Report Coverage and Deliverables

    The “Vascular Closure Device Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering the following areas:

    Vascular Closure Device Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope

    • Market dynamics such as drivers, restraints, and key opportunities

    Vascular Closure Device Market trends

    • Detailed PEST/Porter’s Five Forces and SWOT analysis

    Vascular Closure Device market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments

    Vascular Closure Device Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments

    • Detailed company profiles
    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    Product Type, Access, Procedure, and End User

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    Frequently Asked Questions

    Which region dominated the vascular closure device market in 2023?

    North America dominated the vascular closure device market in 2023

    What are the driving factors impacting the vascular closure device market?

    The increasing prevalence of cardiovascular diseases and burgeoning demand for minimally invasive devices are the major factors fuelling the market growth of vascular closure devices over the years.

    What are the future trends of the vascular closure device market?

    Major market players engage in new product developments, launches, and approvals to ensure the innovation and development of efficient products are likely to remain a key trend in the market.

    Which are the leading players operating in the vascular closure device market?

    Cordis Corp, Transluminal Technologies LLC, Vasorum Ltd, Haemonetics Corp, Abbott Laboratories, Becton Dickinson and Co, Cardinal Health Inc., ENDOCOR GmbH & CO KG, Medtronic Plc, and Teleflex Inc.

    What is the expected CAGR of the vascular closure device market?

    The market is expected to register a CAGR of 7.10% during 2023–2031.

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • 3.1 Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • 3.2 Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • 3.3 Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • 3.4 Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Trends and growth analysis reports related to Vascular Closure Device Market